Chondroitin During Pregnancy: Exploring Safety Concerns

Chondroitin is a glycosaminoglycan found in human milk. It is well tolerated with occasional gastrointestinal upset reported. Although no studies exist on the use of chondroitin supplements during pregnancy, small amounts occur naturally in breast milk. Chondroitin is poorly absorbed orally with a bioavailability of about 10%. It is derived from shark or bovine cartilage and is most commonly used to treat osteoarthritis.

Chondroitin is poorly absorbed orally with a bioavailability of about 10%

Chondroitin is a supplement used to treat osteoarthritis and joint-related conditions. It is a natural substance found in the body that supports the formation of cartilage, ligaments, and tendons. Chondroitin is also found in the fluid that cushions our joints.

Despite the low oral bioavailability, chondroitin has been shown to be effective in treating osteoarthritis symptoms when taken orally. In a study conducted on healthy male volunteers, oral administration of chondroitin sulfate resulted in a significant increase in plasma levels of chondroitin sulfate, with a peak concentration occurring after 2 hours. This indicates that chondroitin is absorbed and can reach the bloodstream, even if the amount absorbed is relatively low.

In terms of safety during pregnancy, there is limited research available. A study by the University of Toronto found no increased risk of major malformations or other adverse fetal effects when pregnant women used glucosamine, which is often combined with chondroitin for osteoarthritis treatment. However, due to the lack of well-controlled studies, it is recommended that pregnant women consult their doctors before taking chondroitin supplements.

It is well tolerated with occasional gastrointestinal upset reported

Chondroitin is a mixture of large glycosaminoglycans and disaccharide polymers, usually derived from shark or bovine cartilage. It is most commonly used to treat osteoarthritis. Chondroitin is poorly absorbed orally with a bioavailability of about 10%. It is well tolerated with occasional gastrointestinal upset reported.

Although no studies exist on the use of chondroitin supplements during breastfeeding, small amounts occur naturally in breast milk. Chondroitin might have an inhibitory effect on microbial binding to cellular receptors in the infant, helping to prevent infections, or acting as an antioxidant to protect the infant from oxidative stress. Mothers of preterm infants excrete greater amounts of chondroitin into breast milk than mothers of full-term infants.

Chondroitin is a normal component of human breast milk

Chondroitin sulfate is well tolerated, with occasional gastrointestinal upset reported. It is poorly absorbed orally, with a bioavailability of about 10%. Pooled human milk from healthy subjects was found to have an average chondroitin sulfate concentration of 231 mg/L, representing 55.5% of all human milk glycosaminoglycans.

Although there are no studies on the use of chondroitin supplements during breastfeeding, the presence of chondroitin in breast milk is thought to be beneficial for the infant. It is believed to protect against bacterial infection and reduce the risk of necrotizing enterocolitis, a devastating intestinal inflammatory disease affecting preterm infants.

Chondroitin may have an inhibitory effect on microbial binding to cellular receptors in the infant

Chondroitin sulfate is a mixture of large glycosaminoglycans and disaccharide polymers, usually derived from shark or bovine cartilage. It is often used to treat osteoarthritis. Chondroitin is poorly absorbed orally, with a bioavailability of about 10%. It is well tolerated, with occasional gastrointestinal upset reported.

Although there are no studies on the use of chondroitin supplements during breastfeeding, small amounts occur naturally in breast milk. Chondroitin may have an inhibitory effect on microbial binding to cellular receptors in the infant, helping to prevent infections or acting as an antioxidant to protect the infant from oxidative stress.

Mothers of preterm infants excrete greater amounts of chondroitin into breast milk than mothers of full-term infants. The use of chondroitin by a nursing mother is unlikely to adversely affect the breastfed infant.

Mothers of preterm infants excrete greater amounts of chondroitin into breast milk than mothers of full-term infants

Chondroitin is a mixture of large glycosaminoglycans and disaccharide polymers, usually derived from shark or bovine cartilage. It is most commonly used to treat osteoarthritis. Chondroitin is poorly absorbed orally with a bioavailability of about 10%. It is well tolerated with occasional gastrointestinal upset reported. Although no studies exist on the use of chondroitin supplements during breastfeeding, small amounts occur naturally in breast milk.

The use of chondroitin by a nursing mother is unlikely to adversely affect the breastfed infant.

Frequently asked questions